Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab

During treatment with fingolimod, B cells are redistributed from blood to secondary lymphoid organs, where they are protected from the effect of anti-CD20 and other cell-depleting therapies. We describe a multiple sclerosis patient who had almost complete depletion of B cells in blood during and sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmøy, Trygve, Torkildsen, Øivind, Zarnovicky, Svetozar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077610/
https://www.ncbi.nlm.nih.gov/pubmed/30112230
http://dx.doi.org/10.1155/2018/5190794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077610/
https://www.ncbi.nlm.nih.gov/pubmed/30112230
http://dx.doi.org/10.1155/2018/5190794

Ejemplares similares